ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0623 • ACR Convergence 2020

    Cytokine Storm: Outcomes in SARS-CoV-2 Patients Treated with Biologics in a Rheumatology Cohort

    Neha Chiruvolu1, Muntarin Karim2, Patil Injean3, Sandy Lee3, Karina Torralba4, Christina Downey3, Mehrnaz Hojjati5, Loomee Doo5, Donna Jose6, Deepa Panikkath3, Micah Yu5, Anna Lafian5, Marven Cabling5 and Vaneet Sandhu7, 1UC Riverside School of Medicine, Riverside, CA, 2Loma Linda University Health System, Loma Linda, CA, 3Loma Linda University Medical Center, Redlands, CA, 4Loma Linda University School of Medicine, Redlands, CA, 5Loma Linda University Medical Center, Loma Linda, CA, 6Loma Linda University Medical Center, Ontario, CA, 7Loma Linda University, Loma Linda, CA

    Background/Purpose: Cytokine Release Syndrome (CRS) or Macrophage Activation Syndrome (MAS) is a life threating hyperinflammatory condition that can complicate rheumatic disease as well as infections…
  • Abstract Number: 0637 • ACR Convergence 2020

    Clinical and Treatment Features of Rheumatoid Arthritis in HIV-Infected Individuals Followed Longitudinally over Time

    Benjamin Naovarat1, Francis Williams1 and John Reveille2, 1The University of Texas McGovern Medical School, Houston, TX, 2Department of Internal Medicine, University of Texas, Houston, TX

    Background/Purpose: With the successful treatment of HIV-1 infection with combination anti-retroviral treatment, immune-mediated diseases that were rarely encountered in HIV positive individuals in the pre-treatment…
  • Abstract Number: 0636 • ACR Convergence 2020

    Rheumatology Patient Experience and Trends During the SARS-COV-2 Pandemic

    Cuoghi Edens1, Kichul Ko1 and Kimberly Trotter1, 1University of Chicago, Chicago, IL

    Background/Purpose: Rheumatic disease patients are counseled on the immunosuppressive aspect of their rheumatic disease treatment and their increased risk of infection.  Little is known about…
  • Abstract Number: 0642 • ACR Convergence 2020

    COVID-19 Infection in Rheumatologic Patients on Treatment with Targeted Therapies

    Marta González Fernández1, Orlando Pompei fernández2, Joaquín María Belzunegui Otano3, Paula García Escudero1, Claudia Stoye2, Juan Ramón De Dios2, Belén Álvarez Rodríguez2, Elena Garmendia Sánchez1, Susana Gil2, Ana Ruibal-Escribano4, Margarida Vasques Rocha2, Francisco García Llorente5, César Antonio Egües6, Edurne Guerrero7 and Jaime Calvo-Alén2, 1Hospital Universitario Cruces, Barakaldo, Spain, 2Hospital Universitario Araba, Vitoria-Gasteiz, Pais Vasco, Spain, 3Rheumatology Service, Hospital Universitario Donostia. San Sebastián, Spain, San Sebastian, Spain, 4Hospital Alfredo Espinosa, Urduliz, Pais Vasco, Spain, 5Hospital Universitario de Galdakao, Galdakao, Pais Vasco, Spain, 6Hospital Universitario Donostia, Donostia-San Sebastián, Pais Vasco, Spain, 7Hospital Alto Deba, Arrasate, Pais Vasco, Spain

    Background/Purpose: SARS COV 2 pandemic has been an issue which has challenged the health care systems around the world. Rheumatology has been involved in two…
  • Abstract Number: 0641 • ACR Convergence 2020

    Cohort of Rheumatic Patients Treated with Rituximab and COVID-19: Does Rituximab Treatment Increases the Severity of SARS-COV2 Infection?

    Antía García-Fernández1, Fernando López-Gutiérrez1, Jesús Loarce-Martos1, Ivan Del Bosque-Granero2, Laura Calvo-Sanz1, Boris Blanco-Cáceres1, Cristina Pijoan-Moratalla1, Lourdes Villalobos-Sánchez3, Javier Bachiller-Corral1 and Mónica Vázquez1, 1Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Spain, 2Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Madrid, Spain, 3Rheumatology, Hospital Universitario Ramón y Cajal, Madrid

    Background/Purpose: There are very few studies reporting COVID-19 in patients with rheumatic diseases, without clear evidence supporting more frequent or severe disease in these patients.…
  • Abstract Number: 0647 • ACR Convergence 2020

    Dual-energy CT versus Ultrasound, Alone or in Combination, for the Diagnosis of Gout: A Diagnostic Performance Study

    Jasvinder Singh1, Fabio Becce2, Jean--Francois Budzik3 and Tristan Pascart4, 1University of Alabama at Birmingham, Birmingham, AL, 2Lausanne University, Lausanne, Switzerland, 3University of Lille, Lille, France, 4Ghicl, Hôpital Saint-Philibert, department of rheumatology, Lomme, France

    Background/Purpose: To examine the diagnostic accuracy of dual-energy computed tomography (DECT) vs. ultrasound  or their combination for the diagnosis of gout.Methods: Using data from an…
  • Abstract Number: 0649 • ACR Convergence 2020

    A Multicenter, Open-Label, Efficacy and Safety Study of Pegloticase in Patients with Uncontrolled Gout Who Have Undergone Kidney Transplantation: Early Data Report

    Abdul Abdellatif1, Lin Zhao2, Paul Peloso3, Katya Cherny2, Brad Marder2, John Scandling4 and Kenneth Saag5, 1Baylor College of Medicine, Division of Nephrology, Houston, TX, 2Horizon Therapeutics plc, Lake Forest, IL, 3Horizon Therapeutics plc, Gurnee, IL, 4Stanford Medicine, Department of Nephrology, Stanford, CA, 5University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology, Birmingham, AL

    Background/Purpose: Gout’s high prevalence in kidney transplant (KT) recipients has been associated with heavy residual urate burden, decreased urate excretion related to reduced renal function,…
  • Abstract Number: 0644 • ACR Convergence 2020

    Characterizations of Cytokine Storm Associated with COVID19

    Ofer Perzon1, Avi Abutbul1, Sigal Sviri1 and Dror Mevorach1, 1Hadassah-University Hospital, Jerusalem, Yerushalayim, Israel

    Background/Purpose: COVID-19, the name given to the clinical syndrome associated with the newly recognized virus SARS-CoV-2 has become pandemic with mortality estimated based on reports…
  • Abstract Number: 0639 • ACR Convergence 2020

    Immunological Abnormalities in a SARS-CoV-2-Cytokine Release Syndrome Rheumatology Cohort

    Patil Injean1, Sandy Lee1, Neha Chiruvolu2, Muntarin Karim3, Loomee Doo4, Deepa Ragesh Panikkath5, Donna Jose4, Micah Yu4, Anna Lafian4, Vaneet Sandhu6, Karina Torralba7, Christina Downey1, Marven Cabling8 and Mehrnaz Hojjati9, 1Loma Linda University Medical Center, Redlands, CA, 2UC Riverside School of Medicine, Riverside, CA, 3Loma Linda University Health System, Loma Linda, CA, 4Loma Linda University Medical Center, Loma Linda, CA, 5Loma Linda University Health, Department of Rheumatology, Loma Linda, CA, 6Loma Linda University, Loma Linda, CA, 7Loma Linda University School of Medicine, Redlands, CA, 8Loma Linda University Medical Center, Loma Linda, 9Loma Linda University, Loma Linda

    Background/Purpose: Cytokine release syndrome (CRS) is a condition characterized by a sepsis-like condition and laboratory abnormalities such as high ferritin, low ESR, and low fibrinogen…
  • Abstract Number: 0652 • ACR Convergence 2020

    Changes in Serum Urate, in the First 6-months of Initiation or Change of Urate-Lowering Therapy, Associate with Immediate Health-Related Quality of Life Outcomes in People with Gout

    Ruth Topless1, Tony Merriman1, Siamak Noorbaloochi2 and Jasvinder Singh3, 1University of Otago, Dunedin, New Zealand, 2University of Minnesota, Minneapolis, 3University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Few studies, if any, have found association of the biochemical cause of gout (high serum urate) with functional limitation and health-related quality of life…
  • Abstract Number: 0655 • ACR Convergence 2020

    Weight Loss as Treatment for Gout in Patients with Concomitant Obesity: A Proof-of-Concept Randomized Controlled Trial

    Kristian Zobbe1, Robin Christensen2, Sabrina Mai Nielsen3, Lisa Stamp4, Marius Henriksen5, Anders Føhrby Overgaard6, Lene Dreyer7, Filip Krag Knop8, Jasvinder Singh9, Michael Doherty10, Pascal Richette11, Arne Astrup12, Karen Ellegaard1, Else Marie Bartels13, Mikael Boesen14, Henrik Rindel Gudbergsen15, Henning Bliddal15 and Lars Erik Kristensen16, 1The Parker Institute - Frederiksberg og Bispebjerg Hospitaler, Copenhagen, Denmark, 2Musculoskeletal Statistics Unit, The Parker Institute/Odense University Hospital, Copenhagen F, Denmark, 3The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark, Frederiksberg, Denmark, 4University of Otago Christchurch, Christchurch, New Zealand, 5The Parker Institute - Frederiksberg og Bispebjerg Hospitaler, Copenhagen, 6The Parker Institute - Frederiksberg og Bispebjerg Hospitaler, Sorø, 7Department of Rheumatology, Aalborg UnIversity Hospital, Aalborg, Denmark, 8Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark, Copenhagen, 9University of Alabama at Birmingham, Birmingham, AL, 10Academic Rheumatology, School of Medicine, University of Nottingham, Nottingham UK, Nottingham, United Kingdom, 11Department of Rheumatology, Lariboisière Hospital, Paris, France, 12Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark, Copenhagen, Denmark, 13Department of Neurology, Bispebjerg-Frederiksberg Hospital, University of Copenhagen, Frederiksberg, Denmark, Copenhagen, Denmark, 14Department of Radiology Copenhagen University hospital Bispebjerg and Frederiksberg; The Parker Institute, Copenhagen, Denmark, 15The Parker Institute - Frederiksberg og Bispebjerg Hospitaler, Frederiksberg, Denmark, 16The Parker Institute Copenhagen Denmark, Copenhagen, Denmark, Bispebjerg and Frederiksberg, Denmark

    Background/Purpose: Despite scarce evidence regarding the effects of weight loss in gout1, international guidelines recommend dietary advice and weight loss as a core management strategy…
  • Abstract Number: 0656 • ACR Convergence 2020

    A Sugar Tax Results in Reduced Incident Gout, Quality Adjusted Life Years Lost and Economic Cost from Gout: A Health Economic Analysis

    Philip Robinson1, Nicola Dalbeth2, Chris Frampton3, Tony Merriman3, Amanda Phipps-Green3 and Peter Donovan4, 1University of Queensland, Herston, Queensland, Australia, 2University of Auckland, Auckland, New Zealand, 3University of Otago, Dunedin, New Zealand, 4Royal Brisbane & Women's Hospital, HERSTON, Queensland, Australia

    Background/Purpose: Intake of sugar is associated with increased incident gout. Sugar taxes have been effective at reducing the intake of sugar in several jurisdictions. We…
  • Abstract Number: 0651 • ACR Convergence 2020

    Readmission Risk and Quality of Care in Patients Presenting to the Emergency Department with Gout Flares

    Luigi Brunetti1, Janaki Vekaria1, Peter Lipsky2 and Naomi Schlesinger3, 1Rutgers Ernest Mario School of Pharmacy, piscataway, NJ, 2AMPEL BioSolutions LLC., Charlottesville, VA, 3Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ

    Background/Purpose: Gout is the most common inflammatory arthritis and its economic burden is substantial, with estimates for the overall cost exceeding $20 billion (US) annually.…
  • Abstract Number: 0659 • ACR Convergence 2020

    Polynesian-Specific Gout-Associated Frameshift Variant in PRPSAP1

    Megan Leask1, Nicola Dalbeth2, Lisa Stamp3, Tony Merriman4, Amanda Phipps-Green4, Ruth Topless4, James Boocock5, Hyon Choi6, Keresoma Leaupepe1 and Eli Stahl7, 1University of Otago, Dunedin, Otago, New Zealand, 2University of Auckland, Auckland, New Zealand, 3University of Otago Christchurch, Christchurch, New Zealand, 4University of Otago, Dunedin, New Zealand, 5David Geffen School of Medicine at UCLA, Los Angeles, CA, 6Massachusetts General Hospital, Department of Medicine, Division of Rheumatology, Lexington, MA, 7Mt Sinai School of Medicine, New York, NY

    Background/Purpose: Polynesian (NZ Māori and Pacific) populations have increased prevalence of gout. Hyperuricaemia is contributed to by increased urate production in the liver via the…
  • Abstract Number: 0654 • ACR Convergence 2020

    The Effects of Dietary Macronutrients on Serum Urate: A Secondary Analysis of the OmniHeart Trial

    Matthew Belanger1, Christina Wee1, Kenneth Mukamal1, Edgar Miller2, Frank Sacks3, Lawrence Appel2, Robert Shmerling4, Hyon Choi5 and Stephen Juraschek1, 1Beth Israel Deaconess Medical Center/Harvard Medical School, Division of General Medicine, Boston, MA, 2Johns Hopkins University, School of Medicine, Department of Medicine, Division of General Internal Medicine, Baltimore, MD, 3Harvard T. H. Chan School of Public Health, Department of Nutrition, Boston, MA, 4Beth Israel Deaconess Medical Center/Harvard Medical School, Division of Rheumatology, Mashpee, MA, 5Massachusetts General Hospital, Department of Medicine, Division of Rheumatology, Lexington, MA

    Background/Purpose: Diet is a significant determinant of hyperuricemia and risk for gout. Dietary recommendations to prevent gout emphasize reducing purine intake; however, low-purine diets are…
  • « Previous Page
  • 1
  • …
  • 668
  • 669
  • 670
  • 671
  • 672
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology